
Swiss drugmaker Novartis raises 2025 forecast after strong Q1 momentum
Audio By Carbonatix By Ludwig Burger FRANKFURT (Reuters) -Novartis released a more optimistic full-year earnings forecast on Tuesday, citing the strong growth of drugs such as Leqvio, Kisqali and Kesimpta during the first quarter. The Swiss drugmaker said …